Business Standard

Zydus settles case with Upsher-Smith on Qudexy

Image

IANS Ahmedabad

Pharmaceuticals company Cadila Healthcare and its subsidiary Zydus Pharmaceuticals (US) have finalised an agreement with Upsher-Smith Laboratories, a regulatory filing said here on Friday.

This would settle all outstanding patent litigation related to Qudexy XR (topiramate) extended-release capsules.

"Under the terms of the agreement, Upsher-Smith grants Zydus a licence to market Zydus' generic version of Qudexy XR beginning March 19, 2020, or earlier under certain circumstances," the filing with the BSE said.

However, other terms of the settlement were not disclosed.

--IANS

ag/in/dg

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 13 2017 | 2:24 PM IST

Explore News